BioMed Realty, a Blackstone portfolio company, is a leading provider of real estate solutions to the life science and technology industries. BioMed owns and operates high quality life science real estate comprising 16.4 million square feet concentrated in leading innovation markets throughout the United States and United Kingdom, including Boston/Cambridge, San Francisco, San Diego, Seattle, Boulder and Cambridge, U.K. In addition, BioMed maintains a premier development platform with 3.4 million square feet of Class A properties in active construction to meet the growing demand of the life science industry.
An unmatched expertise in a full range of real estate services
Leasing
Our leasing team creates lasting partnerships with our tenants through unique and trusted expertise.
Development
Our team has decades of experience delivering ground-up development projects on time and on budget.
Acquisition
Every buying opportunity is evaluated to meet our standards for quality, location and long-term value.
Financing
Our skilled Finance team establishes unique and creative solutions for our tenants.
Asset Management
Our tenants know whom to call for help. Our team will respond quickly to keep their operations running smoothly.
BioMed Realty is a true real estate partner because they understand the sector and provide creative and flexible solutions. The needs of life science organizations require facilities that are easy to operate, so that we can focus our energies on our ground breaking science.
Malcolm WeirChief Executive Officer, Heptares - Granta Park, U.K.
As we have expanded our footprint at the Pacific Research Center over the course of the past 10+ years, BioMed Realty has been with us every step of the way by accommodating our growth in one of the most dynamic life science innovation markets in the world.
Brian BlaggVice President of Engineering, Facilities, EH&S and Supply Chain - Revance
Recruiting and retaining a first-class work force is critical for us. BioMed Realty has created an environment for our team at Granta Park, which helps us become employers of choice.
Jonathan Green VP, Site General Manager - Medimmune (Cambridge, U.K.)
Vertically Integrated
By offering a full range of services from leasing to development to property management to facilities, we can assist our customers at any stage. Our experience lives in house, providing greater control to our team and responsiveness to our tenants.
Collaborative
The foundation of our business is trust, flexibility and dedication. By focusing on the unique needs of life science organizations and doing what we say we are going to do, we work every day to earn the confidence of tenants, brokers and business partners.
Established
We own and operate a fully international portfolio of properties of high quality life science real estate strategically located in each of the core life science markets in the United States and United Kingdom.
Knowledgeable
As pioneers in the life science real estate industry, and by making relationships the priority, our team of 286+ best-in-class professionals are able to achieve the best results for our tenants and business partners.
Our leadership team
Our team is comprised of smart, driven, and creative people who go above and beyond to form and further strengthen valuable relationships with our life science clients and the broader industry. At BioMed Realty, your success is our success.
Tim SchoenCEO
Jonathan BergschneiderPresident - West Coast Markets
William KanePresident - East Coast and United Kingdom Markets
Blackstone is one of the world’s leading investment firms. At Blackstone, we seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work.
BioMed Realty uses cookies to compile aggregate data about website traffic and interactions so that we can offer a better site experience and content in the future. We use third party companies such as Google Analytics to assist us in understanding our website visitors. Read more about our terms & privacy policy, and UK Modern Slavery Act Transparency Statement 2018.
